Last reviewed · How we verify

NCT06904560

The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort

Not yet recruiting NA Last updated 1 April 2025
What this trial tests

NA trial testing phacoemulsification in Corneal Diseases in 40 participants. Not yet recruiting.

Timeline
1 April 2025
Primary endpoint
1 June 2025
1 July 2025

Quick facts

Lead sponsorSohag University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment40
Start date1 April 2025
Primary completion1 June 2025
Estimated completion1 July 2025

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 40 to 80, any sex, with Corneal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of phacoemulsification

Trials testing the same drug.

Other recruiting trials for Corneal Diseases

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06904560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing